Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 1350 of 46697 entries
View as:
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 21
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 16
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 62
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 8
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 6
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 18
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Ahmet Yuksek | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Ahmet Yuksek.temp.org | 2025-07-14 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | - | 21 | 0.0% | 0 | 0 | 0.0% | - | Ahn-Gook Pharmaceuticals Co.,Ltd.temp.org | 2025-07-14 |
| Ahon Pharmaceutical Co., Ltd. | - | 16 | 0.0% | 0 | 0 | 0.0% | - | Ahon Pharmaceutical Co., Ltd..temp.org | 2025-07-14 |
| Ahram Canadian University | - | 62 | 0.0% | 0 | 0 | 0.0% | - | Ahram Canadian University.temp.org | 2025-07-14 |
| Ahuva D Cices | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Ahuva D Cices.temp.org | 2025-07-14 |
| Ahvaz Jundishapur University of Medical Sciences | - | 8 | 0.0% | 0 | 0 | 0.0% | - | Ahvaz Jundishapur University of Medical Sciences.temp.org | 2025-07-14 |
| Ai Peng | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Ai Peng.temp.org | 2025-07-14 |
| Ai-Ling Chang | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Ai-Ling Chang.temp.org | 2025-07-14 |
| AiCure | - | 2 | 0.0% | 0 | 0 | 0.0% | - | AiCure.temp.org | 2025-07-14 |
| AiCuris Anti-infective Cures AG | - | 8 | 0.0% | 0 | 0 | 0.0% | - | AiCuris Anti-infective Cures AG.temp.org | 2025-07-14 |
| AiViva BioPharma, Inc. | - | 6 | 0.0% | 0 | 0 | 0.0% | - | AiViva BioPharma, Inc..temp.org | 2025-07-14 |
| Aiberry, Inc | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aiberry, Inc.temp.org | 2025-07-14 |
| Aibin Liang，MD，Ph.D. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Aibin Liang，MD，Ph.D..temp.org | 2025-07-14 |
| Aichi Cancer Center | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aichi Cancer Center.temp.org | 2025-07-14 |
| Aichi Gakuin University | - | 6 | 0.0% | 0 | 0 | 0.0% | - | Aichi Gakuin University.temp.org | 2025-07-14 |
| Aichi Medical University | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aichi Medical University.temp.org | 2025-07-14 |
| Aida Najafian | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aida Najafian.temp.org | 2025-07-14 |
| Aidan Products LLC | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aidan Products LLC.temp.org | 2025-07-14 |
| Aiden Abidov | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Aiden Abidov.temp.org | 2025-07-14 |
| Aidence | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aidence.temp.org | 2025-07-14 |
| Aier Eye Hospital, Changsha | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aier Eye Hospital, Changsha.temp.org | 2025-07-14 |
| Aier Eye Hospital, Guangzhou | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aier Eye Hospital, Guangzhou.temp.org | 2025-07-14 |
| Aier School of Ophthalmology, Central South University | - | 18 | 0.0% | 0 | 0 | 0.0% | - | Aier School of Ophthalmology, Central South University.temp.org | 2025-07-14 |
| Aifred Health | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aifred Health.temp.org | 2025-07-14 |
| Aifred Health Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aifred Health Inc..temp.org | 2025-07-14 |